Vadino; Winston A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vadino; Winston A..The latest application filed is for "pharmaceutical compositions and uses thereof".

Company Profile

1.18.1

Vadino; Winston A. - Whitehouse Station NJ
Vadino; Winston A. - Bridgewater NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical compositions and uses thereof Grant 11,179,377 - Straub , et al. November 23, 2	2021-11-23
Pharmaceutical Compositions And Uses Thereof App 20200054615 - Straub; Julie ; et al.	2020-02-20
Orally administrable solid ribavirin dosage forms and process for making them Grant 6,337,090 - Liebowitz , et al. January 8, 2	2002-01-08
Orally administrable solid dosage form Grant 6,335,032 - Liebowitz , et al. January 1, 2	2002-01-01
Orally administrable solid dosage form Grant 6,051,252 - Liebowitz , et al. April 18, 2	2000-04-18
Solid solution of an antifungal agent with enhanced bioavailability Grant 5,972,381 - Sangekar , et al. October 26, 1	1999-10-26
Process of making solid ribavirin dosage forms Grant 5,916,594 - Liebowitz , et al. June 29, 1	1999-06-29
Orally administrable solid dosage form Grant 5,914,128 - Liebowitz , et al. June 22, 1	1999-06-22
Oral antifungal composition Grant 5,846,971 - Sangekar , et al. December 8, 1	1998-12-08
Antifungal composition with enhanced bioavailability Grant 5,834,472 - Sangekar , et al. November 10, 1	1998-11-10
Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine Grant 5,100,675 - Cho , et al. March 31, 1	1992-03-31
Long acting diltiazem formulation Grant 5,000,962 - Sangekar , et al. March 19, 1	1991-03-19
Immediate release diltiazem formulation Grant 4,992,277 - Sangekar , et al. February 12, 1	1991-02-12
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine Grant 4,990,535 - Cho , et al. February 5, 1	1991-02-05
Sustained release labetalol tablets Grant 4,940,580 - Sangekar , et al. July 10, 1	1990-07-10
Controlled-release dosage form comprising acetaminophen, pseudoephedrine and dexbrompheniramine Grant 4,777,050 - Vadino October 11, 1	1988-10-11
Controlled release dosage forms comprising hydroxypropylmethylcellulose Grant 4,695,591 - Hanna , et al. September 22, 1	1987-09-22
Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate Grant 4,657,757 - Hanna , et al. April 14, 1	1987-04-14
Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate Grant 4,601,894 - Hanna , et al. July 22, 1	1986-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.